- Disease: Acute SARS-CoV-2, Avian Influenza, Influenza
- Study type: Adaptive Platform Trial
- Study aim: To identify effective novel interventions that reduce mortality and improve outcomes in patients with acute hypoxaemic respiratory failure due to Acute Respiratory Distress Syndrome
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from
Study Data
- Adults
- General population
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Pharmacological intervention
- Immnunomodulator
- Baricitinib
- Statins
- Simvastatin
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to